From January 1, 2022 to March 31, 2022, the company has repurchased 653,900 shares, representing 1.45% for ¥1,282.85 million. With this, the company has completed the repurchase of 719,400 shares, representing 1.6% for ¥1,411.44 million under the buyback announced on November 4, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,110 JPY | +0.48% | +1.15% | +4.61% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.61% | 576M | |
+20.39% | 43.67B | |
+26.21% | 22.79B | |
+21.14% | 15.45B | |
+18.82% | 14.29B | |
+53.37% | 12.83B | |
-0.05% | 6.79B | |
-11.88% | 6.52B | |
+12.62% | 5.59B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- 4559 Stock
- News Zeria Pharmaceutical Co., Ltd.
- Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 4, 2021.